| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 09/28/2006 | CA2602583A1 Biaryl derived amide modulators of vanilloid vr1 receptor |
| 09/28/2006 | CA2602445A1 Metabolites for nk-i antagonists for emesis |
| 09/28/2006 | CA2600578A1 Carboxanilides as microbiocides |
| 09/28/2006 | CA2598589A1 11-beta-hydroxysteroid dehydrogenase inhibitors |
| 09/27/2006 | EP1705179A1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 09/27/2006 | EP1704856A1 Hsp90 family protein inhibitor |
| 09/27/2006 | EP1703976A2 Use of metal complex compounds comprising pyridine, pyrimidine or s-triazine derived ligands as catalysts for oxidations with organic peroxy acids and/or precursors of organic peroxy acids and h2o2 |
| 09/27/2006 | EP1703909A1 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
| 09/27/2006 | EP1703908A1 Aryl sulfonamide compounds and uses related thereto |
| 09/27/2006 | EP1592696B1 Salts comprising cyanoborate anions |
| 09/27/2006 | EP0873343B1 Metal complex source reagents for chemical vapor deposition |
| 09/27/2006 | CN1839136A Pyrazolopyrimidines |
| 09/27/2006 | CN1839127A Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole |
| 09/27/2006 | CN1839126A Novel cyanopyridine derivatives useful in the treatment of cancer and other disorders |
| 09/27/2006 | CN1839121A Hydroxamic acid compounds and methods of use thereof |
| 09/27/2006 | CN1837195A Pyridine derivatives as nmda-receptor subtype blockers |
| 09/27/2006 | CN1276914C Novel cyclohexyl sulphones |
| 09/26/2006 | US7112674 cyclized; organic light-emitting diodes (OLED); eliminate drawbacks of Alq3 as emitter and a host material for dopants; narrower emission bands; broad spectral range; low driver voltages; high photometric efficiency (low power consumption); high luminance (emission intensity); high thermal stability |
| 09/26/2006 | US7112595 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 09/26/2006 | US7112586 Substituted diamine derivatives useful as motilin antagonists |
| 09/26/2006 | CA2278694C Sulfamide-metalloprotease inhibitors |
| 09/21/2006 | WO2006099075A2 Certain substituted amides, method of making, and method of use thereof |
| 09/21/2006 | WO2006098684A1 Novel compounds ii 2-pyridine derivatives as inhibitors of neutrophile elastase. |
| 09/21/2006 | WO2006098683A1 2-pyridine derivatives as inhibitors of neutrophile elastase |
| 09/21/2006 | WO2006098308A1 Novel anthranilic acid derivative or salt thereof |
| 09/21/2006 | WO2006097817A1 N- (n-sulfonylaminomethyl) cyclopropanecarboxamide derivatives useful for the treatment of pain |
| 09/21/2006 | WO2006097766A1 Arylsulfonyl benzyl ethers as 5-ht2a antagonists |
| 09/21/2006 | WO2006097490A1 Nicotinanilides method for production thereof and agents comprising the same for prevention of fungal pests |
| 09/21/2006 | WO2006097489A1 Biphenyl-n-(4-pyridyl) methylsufonamides |
| 09/21/2006 | WO2006097488A1 Use of n- (4-pyridyl) methylsulfonamides for combating arthropodal pests |
| 09/21/2006 | WO2006097130A1 Compounds absorbing uv light and blue light, as a medium for optical data storage |
| 09/21/2006 | WO2006067587A3 Nonnucleoside inhibitors of hiv-1 reverse transcriptase |
| 09/21/2006 | WO2006065590A3 Pyridine and pyrimidine antiviral compositions |
| 09/21/2006 | WO2006063294A3 Novel inhibitors of histone deacetylase for the treatment of disease |
| 09/21/2006 | WO2006048152A3 Dicarboxamide derivatives and their use as factor xa inhibitors |
| 09/21/2006 | WO2005037207A3 Arylalkyl-piperazine derivatives for the treatment of conditions ameliorated by monoamine reuptake including vasomotor symptoms (vms) |
| 09/21/2006 | US20060211892 Bridged bi-aromatic ligands, catalysts, processes for polymerizing and polymers therefrom |
| 09/21/2006 | US20060211865 Use of pyridine N-oxide analogs at doses which do not induce emesis |
| 09/21/2006 | US20060211741 2-Methyl-N-((1R)-1-{6-methyl-5-[(methylsulfonyl)amino]pyridin-2-yl}ethyl)-2-[4-(2,2,2-trifluoro-1, 1-dimethylethyl)phenyl]cyclopropanecarboxamide; analgesics; bioavailability; less drug-drug interaction; solubility; nervous system disorders; headaches; carpal tunnel syndrome; antiinflamatory agents |
| 09/21/2006 | US20060211740 Novel compounds |
| 09/21/2006 | US20060211732 Hydroxamic acid derivatives as antibacterials |
| 09/21/2006 | US20060211731 New substituted pyridine or piperidine compounds |
| 09/21/2006 | US20060211719 Heteroaryl aminoguanidine and alkoxyguanidines and their use as protease inhibitors |
| 09/21/2006 | US20060211694 antiinflammatory agent for treating asthma and chronic pulmonary inflammatory disease |
| 09/21/2006 | US20060211680 decreases expression of a Type I collage gene in a tissue to induce a reduction in accumulation of collagen and thereby improves tissue fibrosis |
| 09/21/2006 | CA2602609A1 Novel anthranilic acid derivative or salt thereof |
| 09/21/2006 | CA2601628A1 Certain substituted amides, method of making, and method of use thereof |
| 09/21/2006 | CA2601468A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 09/21/2006 | CA2601455A1 Dimeric and trimeric nucleic acid dyes, and associated systems and methods |
| 09/21/2006 | CA2600508A1 Arylsulfonyl benzyl ethers as 5-ht2a antagonists |
| 09/21/2006 | CA2600038A1 2-pyridine derivatives as inhibitors of neutrophile elastase |
| 09/21/2006 | CA2599555A1 Biphenyl-n-(4-pyridyl) methylsufonamides |
| 09/21/2006 | CA2599551A1 Use of n- (4-pyridyl) methylsulfonamides for combating arthropodal pests |
| 09/20/2006 | EP1702917A1 Amide derivative and medicine |
| 09/20/2006 | EP1702910A1 Octahydronaphthalene derivative and medicine |
| 09/20/2006 | EP1701953A1 Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist |
| 09/20/2006 | EP1701946A2 Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme |
| 09/20/2006 | EP1701942A1 Non-nucleotide reverse transcriptase inhibitors |
| 09/20/2006 | EP1701941A1 Compounds for treatment of cell proliferative diseases |
| 09/20/2006 | EP1392363B1 Use of mGLuR5 antagonists in the manufacture of a medicament in the treatment of Fragile X syndrome, Autism and Mental Retardation |
| 09/20/2006 | EP1244627B1 Picolinic acid derivatives and their use as fungicides |
| 09/20/2006 | CN1835922A Process for preparation of 4-aryl-nicotinamide derivatives |
| 09/20/2006 | CN1835914A New benzamides as PPAR[upsilon] modulators |
| 09/20/2006 | CN1835751A Therapeutic agents useful for treating pain |
| 09/20/2006 | CN1276035C Water-color ink |
| 09/20/2006 | CN1275967C Benzensulfonic acid indol-5-yl esters and antigonists of the 5-HT6 receptor |
| 09/20/2006 | CN1275943C Crystalline hydrates of nicotinic acid anilide and benzoyl anilide derivatives |
| 09/20/2006 | CN1275938C Thyroid hormone receptor atagonists for treating cardiac and metabolic disorders II |
| 09/20/2006 | CN1275917C Glucocorticoid receptor modulators |
| 09/19/2006 | US7109336 Azo compound and process of producing the same, and novel compound and process of producing azo compounds using the same |
| 09/19/2006 | US7109243 Inhibitors of cathepsin S |
| 09/19/2006 | US7109239 for oral administration using sustained release dosage forms; baclofen and baclofen analogs |
| 09/19/2006 | US7109220 cyclin dependent kinase (CDK) inhibitors useful in treating or ameliorating a CDK mediated disorder consisting of cervical adenocarcinoma, colon carcinoma and malignant melanoma |
| 09/19/2006 | US7109218 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same |
| 09/19/2006 | US7109216 For therapy of psychiatric and neurological disorders |
| 09/19/2006 | US7109215 Compounds possessing neuronal activity |
| 09/19/2006 | US7109203 for use in the treatment or prevention of diseases in which bradykinin B1 receptor activation plays a role |
| 09/19/2006 | US7109199 5-(2,3-Difluorophenyl)-1H-pyrazolo(3,4-c)pyridazin-3-ylamine, e.g.; an enzyme inhibitor of GSK-3, a serine/threonine protein kinase; neuroprotectants in treatment of acute stroke, neurotraumatic injuries and diabetic conditions |
| 09/19/2006 | US7109197 Plant safening agents; nematocides; fungicides; bactericides; viricides |
| 09/19/2006 | US7109191 for inhibiting bone resorption, restenosis, atherosclerosis, inflammatory arthritis, diabetic retinopathy, macular degeneration, angiogenesis, cancer |
| 09/19/2006 | US7108727 Reactive dyes and the use thereof for dyeing substrates containing nucleophilic groups |
| 09/19/2006 | CA2401546C Preparation of derivatives of 3-sulfonamido-4-phenylaminopyridine |
| 09/14/2006 | WO2006096370A1 Polymer ionic electrolytes |
| 09/14/2006 | WO2006095624A1 Protease inhibitor |
| 09/14/2006 | WO2006095205A1 Heteroarylsulfonyl stilbenes as 5-ht2a antagonists |
| 09/14/2006 | WO2006094843A1 Piperazine derivatives as glyt1 inhibitors |
| 09/14/2006 | WO2006094842A1 Acylated piperidihes as glycine transporter inhibitors |
| 09/14/2006 | WO2006094639A1 Pyridine-2-carboxamide derivatives as mglur5 antagonists |
| 09/14/2006 | WO2006067450A3 Modulator |
| 09/14/2006 | WO2006067445A3 Csf-1r kinase inhibitors |
| 09/14/2006 | WO2004073634A3 Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists |
| 09/14/2006 | US20060205951 New crystal modification of torasemide |
| 09/14/2006 | US20060205794 e.g. 4-{(1R)-2-[(6-{4-[3-(Cyclopentylsulfinyl)phenyl]butoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol; beta 2-adrenoreceptor agonist; asthma, chronic obstructive pulmanory disease, bronchitis; antidepressant |
| 09/14/2006 | US20060205772 Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase type I |
| 09/14/2006 | US20060205748 Heterocyclic diamide invertebrate pest control agents |
| 09/14/2006 | US20060205739 Aroylfuranes and aroylthiophenes |
| 09/14/2006 | US20060205732 Nonphytotoxic; 4-Bromo-3-methoxy-N-4-[4(trifluoromethyl)phenoxy]phenyl-thiophene-2-carboxamide; 4-[(Allyloxycarbonyl)amino]-3-methoxy-N-4-[4-(trifluoromethyl)phenoxy]phenyl-thiophene-2-carboxamide |
| 09/14/2006 | US20060205726 e.g. 2-(2-{3-acetoxy-4-[(4'-trifluoromethylbiphenyl-2-carbonyl)amino]phenyl}acetoxymethyl)-2-phenylmalonic acid diethyl ester; microsomal triglyceride transfer protein inhibitor in small intestine; antihyperlipidemic, antidiabetic agent; arteriosclerosis, coronary artery diseases, obesity |
| 09/14/2006 | US20060205715 6-(8-Pentylamino-5,6,7,8-tetrahydro-naphthalen-2-yloxy)-nicotinamide; increase metabolic energy consumption, and reduction of weight; obesity, antidiabetic agent, eating disorders; antidepressant, anxiolytic agent |
| 09/14/2006 | US20060205713 Antidiabetic agents; disease of glucose tolerance; insulin resistance; obesity; dyslipidemia; metabolic disorders; liver disorders; [4-(6-Phenethyloxy-pyridazin-3-yl)piperazin-1-yl]-(2-trifluoromethyl-phenyl)-methanone; stearoyl-CoA desaturase modulators |